Document:

EX-4.4

 Exhibit 4.4 

UNITEDHEALTH GROUP INCORPORATED 

$1,100,000,000 4.450% Notes due December 15, 2048 

Officers’ Certificate and Company Order 

Pursuant to the Indenture, dated as of February 4, 2008 (the “Indenture”), between UnitedHealth Group Incorporated, a Delaware
corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”), and resolutions adopted by the Company’s Board of Directors on October 30, 2007, this Officers’ Certificate and Company
Order is being delivered to the Trustee to establish the terms of a series of Securities in accordance with Section 301 of the Indenture, to establish the form of the Securities of such series in accordance with Section 201 of the
Indenture, to request the authentication and delivery of the Securities of such series pursuant to Section 303 of the Indenture and to comply with the provisions of Section 102 of the Indenture. This Officers’ Certificate and Company
Order shall be treated for all purposes under the Indenture as a supplemental indenture thereto. 
 All conditions precedent provided for in
the Indenture relating to (i) the establishment of a series of Securities, (ii) the establishment of the form of Securities of such series and (iii) the procedures for authentication and delivery of such series of Securities have been
complied with. 
 Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to them in the Indenture.

  

	A.	 Establishment of a Series of Securities pursuant to Section 301 of the Indenture.

 There is hereby established pursuant to Section 301 of the Indenture a series of Securities which shall have the
following terms: 
  

	 	(1)	 The Securities shall bear the title “4.450% Notes due December 15, 2048” (referred to herein as the
“Notes”). 

  

	 	(2)	 The aggregate principal amount of the Notes to be issued pursuant to this Officers’ Certificate and
Company Order shall be limited to $1,100,000,000 except for (a) Notes authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Notes pursuant to Section 304, 305, 306, or 1007 of the
Indenture, (b) Notes which, pursuant to Section 303 of the Indenture, are deemed never to have been authenticated and delivered thereunder and (c) any Securities of this series which are issued in the manner contemplated by paragraph
19(a) hereof. 

  

	 	(3)	 Interest shall be payable to the Person in whose name a Note (or any Predecessor Security) is registered at the
close of business on the Regular Record Date (as defined below) immediately preceding each Interest Payment Date (as defined below). In the event that any Interest Payment Date, the date of maturity or any date of repurchase or Redemption Date falls
on a date that is not a Business Day (as defined below), the related payment of principal and interest shall be postponed to the next succeeding Business Day, but the payment made on such date will be treated as being made on the date that the
payment was first due and the holders of the Notes shall not be entitled to any further interest or other payments with respect to such postponement. “Business Day” shall mean any day other than a Saturday, a Sunday or a day on which
banking institutions in New York, New York or Minneapolis, Minnesota are authorized or required by law, regulation or executive order to close. 

  

	 	(4)	 The Stated Maturity of the Notes shall be December 15, 2048. 

 

	 	(5)	 The Notes shall bear interest at the rate of 4.450% per annum (based upon a
360-day year of twelve 30-day months), from December 17, 2018 or from the most recent Interest Payment Date

	 	
to which interest has been paid or duly provided for, as the case may be, payable semi-annually in arrears on June 15 and December 15 in each year, commencing
June 15, 2019, until the principal thereof is paid or made available for payment. Each such June 15 and December 15 shall be an “Interest Payment Date” for the Notes, and each June 1 and December 1
(whether or not a Business Day), as the case may be, immediately preceding an Interest Payment Date for the Notes shall be the “Regular Record Date” for the interest payable on such Interest Payment Date. 

The provision related to interest on overdue principal in Section 501 of the Indenture shall not be applicable to the Notes. 

 

	 	(6)	 Principal of (and premium, if any) and interest on the Notes will be payable, and, except as provided in
Section 305 of the Indenture with respect to a Global Security (as defined below), the transfer of the Notes will be registrable and Notes will be exchangeable for notes bearing identical terms and provisions at the corporate trust office of
U.S. Bank National Association, in St. Paul, Minnesota. The method of such payment shall be by wire transfer for Notes held in book-entry form or at the option of the Company by check mailed to the Person entitled thereto as shown on the Security
Register. 

  

	 	(7)	 The Notes will be subject to redemption, in whole or in part, at any time and from time to time before
June 15, 2048 (six months prior to their Stated Maturity), at the option of the Company at a Redemption Price equal to the greater of (i) 100% of the principal amount of the Notes to be redeemed and (ii) the sum of the
present values of the remaining scheduled payments of principal and interest on the Notes to be redeemed (excluding the portion of any such interest accrued to the Redemption Date) that would be due if such Notes matured on June 15, 2048,
discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Yield (as defined below), plus
20 basis points, plus, in each case, accrued and unpaid interest thereon to, but not including, the Redemption Date. 

At any time on or after June 15, 2048 (six months prior to their Stated Maturity), the Notes will be redeemable, in whole or in
part at any time and from time to time, at the option of the Company, at a Redemption Price equal to 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest thereon to, but not including, the Redemption Date. 

For this purpose, the following terms have the following meanings: 
  

	 	•	 	 “Treasury Yield” means, with respect to any Redemption Date, the rate per year equal to the semi-annual
equivalent yield to maturity or interpolated (on a day-count basis) yield to maturity of the applicable Comparable Treasury Issue, assuming a price for such Comparable Treasury Issue (expressed as a percentage
of its principal amount) equal to the applicable Comparable Treasury Price for such Redemption Date. 

  

	 	•	 	 “Comparable Treasury Issue” means the United States Treasury security selected by an Independent
Investment Banker appointed by the Trustee after consultation with the Company as having an actual or interpolated maturity comparable to the remaining term of the Notes being redeemed (assuming that the Notes matured on June 15, 2048), or such
other maturity that would be utilized at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes being redeemed.

  

	 	•	 	 “Comparable Treasury Price” means, with respect to any Redemption Date, (i) the average of the
Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations for such Redemption Date, or (ii) if the Trustee obtains fewer than four such Reference Treasury
Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. 

  
 2 

	 	•	 	 “Independent Investment Banker” means any of J.P. Morgan Securities LLC, Citigroup Global Markets Inc.,
Deutsche Bank Securities Inc., Mizuho Securities USA LLC, U.S. Bancorp Investments, Inc. or their respective successors or, if such firms are unwilling or unable to select the Comparable Treasury Issue, one of the remaining Reference Treasury
Dealers appointed by the Trustee after consultation with the Company. 

  

	 	•	 	 “Reference Treasury Dealer” means each of (i) J.P. Morgan Securities LLC, Citigroup Global Markets
Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC or their affiliates; (ii) any other primary U.S. Government securities dealer in the United States (a “Primary Treasury Dealer”) designated by, and not affiliated with,
J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC or U.S. Bancorp Investments, Inc.; provided, however, in the case of (i) and (ii), that if any of the foregoing shall cease to
be a Primary Treasury Dealer, the Company will appoint another Primary Treasury Dealer as a substitute for such entity; and (iii) any other Primary Treasury Dealer selected by the Trustee. 

 

	 	•	 	 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any
Redemption Date, the average, as determined by the Trustee, of the bid and asked prices for the applicable Comparable Treasury Issue (expressed, in each case, as a percentage of its principal amount) quoted in writing to the Trustee by such
Reference Treasury Dealer at 5:00 p.m. on the third Business Day preceding such Redemption Date. 

 A notice of redemption
may provide that it is subject to certain conditions that will be specified in the notice. If those conditions are not met, the redemption notice will be of no effect and the Company will not be obligated to redeem the Notes. 

A partial redemption of the Notes may be effected on a pro rata basis (and in such manner as complies with applicable legal and stock exchange
requirements, if any) or in such method as the Trustee, in the exercise of its reasonable discretion, deems fair and appropriate. The Trustee may provide for the selection for redemption of portions in amounts of $1,000 or whole multiples of $1,000;
except that if all of the Notes of a Holder are to be redeemed, the entire outstanding amount of Notes held by such Holder, even if not a multiple of $1,000, shall be redeemed. 

Notice of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each Holder of the Notes to
be redeemed. 
 Unless any Note called for redemption shall not be paid upon surrender thereof for redemption, on and after the Redemption
Date interest will cease to accrue on the Notes or portions thereof called for redemption. 
  

	 	(8)	 The Company shall not be obligated to redeem or purchase any Notes pursuant to any sinking fund or analogous
provisions. 

  

	 	(9)	 If a Change of Control Triggering Event (as defined below) occurs, unless the Company has exercised its option
to redeem all the Notes of this series, the Company shall be required to make an offer (a “Change of Control Offer”) to each Holder of the Notes of this series to 

  
 3 

	 	
repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Notes on the terms set forth herein. In a Change of Control Offer, the
Company shall be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes of this series repurchased, plus accrued and unpaid interest, if any, on the Notes of this series repurchased to, but not including, the date
of repurchase (a “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event or, at the Company’s option, prior to any Change of Control, but after public announcement of the transaction that
constitutes or may constitute the Change of Control, a notice shall be transmitted to Holders of the Notes of this series describing the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to repurchase
such Notes on the date specified in the notice, which date shall be no earlier than 30 days and no later than 60 days from the date such notice is transmitted (a “Change of Control Payment Date”). The notice shall, if transmitted prior to
the date of consummation of the Change of Control, state that the Change of Control Offer is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date. 

In order to accept the Change of Control Offer, the Holder must deliver to the Paying Agent, at least five Business Days prior to the Change
of Control Payment Date, the Holder’s Note together with the form entitled “Election Form” (which form is annexed to the Note) duly completed, or a telegram, telex, facsimile transmission or a letter from a member of a national
securities exchange, or the Financial Industry Regulatory Authority or a commercial bank or trust company in the United States setting forth: 
  

	 	(i)	 the name of the Holder of the Note; 

 

	 	(ii)	 the principal amount of the Note; 

 

	 	(iii)	 the principal amount of the Note to be repurchased; 

 

	 	(iv)	 the certificate number or a description of the tenor and terms of the Note; 

 

	 	(v)	 a statement that the Holder is accepting the Change of Control Offer; and 

 

	 	(vi)	 a guarantee that the Note, together with the form entitled “Election Form” duly completed, will be
received by the Paying Agent at least five Business Days prior to the Change of Control Payment Date. 

 Any exercise by a
Holder of its election to accept the Change of Control Offer shall be irrevocable. The Change of Control Offer may be accepted for less than the entire principal amount of the Note, but in that event the principal amount of the Note remaining
outstanding after repurchase must be equal to $2,000 or an integral multiple of $1,000 in excess thereof. 
 On the Change of Control
Payment Date, the Company shall, to the extent lawful: 
  

	 	(i)	 accept for payment all Notes of this series or portions of such Notes properly tendered pursuant to the Change
of Control Offer; 

  

	 	(ii)	 deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes of this
series or portions of such Notes properly tendered; and 

  

	 	(iii)	 deliver or cause to be delivered to the Trustee the Notes of this series properly accepted together with an
Officers’ Certificate stating the aggregate principal amount of Notes of this series or portions of such Notes being repurchased. 

  
 4 

 The Company shall not be required to make a Change of Control Offer upon the occurrence of
a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party purchases all Notes of this series properly
tendered and not withdrawn under its offer. In addition, the Company shall not repurchase any Notes of this series if there has occurred and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a
default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. 
 The Company shall comply with the
requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Notes of this series as a result of a Change of Control Triggering Event. To the extent that the provisions of any such securities laws or regulations conflict with the Change of
Control Offer provisions of the Notes of this series, the Company shall comply with those securities laws and regulations and shall not be deemed to have breached its obligations under the Change of Control Offer provisions of the Notes of this
series by virtue of any such conflict. 
 For purposes of the Change of Control Offer provisions of the Notes of this series, the following
terms have the following meanings: 
  

	 	•	 	 “Change of Control” means the occurrence of any of the following: (1) the direct or indirect sale,
lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to any
person, other than the Company or a Subsidiary; (2) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the Company’s outstanding Voting Stock or other Voting Stock into which the
Company’s Voting Stock is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares; (3) the Company consolidates with, or merges with or into, any person, or any person consolidates with, or
merges with or into, the Company, in any such event pursuant to a transaction in which any of the Company’s outstanding Voting Stock or the Voting Stock of such other person is converted into or exchanged for cash, securities or other property,
other than any such transaction where the shares of the Company’s Voting Stock outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving person or any
direct or indirect parent company of the surviving person immediately after giving effect to such transaction; (4) the first day on which a majority of the members of the Company’s Board of Directors are not Continuing Directors; or
(5) the adoption of a plan relating to the Company’s liquidation or dissolution. Notwithstanding the foregoing, a transaction shall not be deemed to involve a Change of Control under clause (2) above if (i) the Company becomes a
direct or indirect wholly-owned subsidiary of a holding company and (ii)(A) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company’s Voting Stock immediately prior to that transaction or (B) immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or
indirectly, of more than 50% of the Voting Stock of such holding company. The term “person,” as used in this definition, has the meaning given thereto in Section 13(d)(3) of the Exchange Act. 

  
 5 

	 	•	 	 “Change of Control Triggering Event” means the occurrence of both a Change of Control and a Rating
Event. 

  

	 	•	 	 “Continuing Directors” means, as of any date of determination, any member of the Company’s Board
of Directors who (1) was a member of such Board of Directors on the date the Notes of this series were issued or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the
Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of the Company’s proxy statement in which such member was named as a nominee for
election as a director). 

  

	 	•	 	 “Fitch” means Fitch, Inc., and its successors. 

 

	 	•	 	 “Investment Grade Rating” means a rating equal to or higher than
BBB- (or the equivalent) by Fitch, Baa3 (or the equivalent) by Moody’s and BBB- (or the equivalent) by S&P, and the equivalent investment grade credit rating
from any replacement Rating Agency or Rating Agencies selected by the Company. 

  

	 	•	 	 “Moody’s” means Moody’s Investors Service, Inc., and its successors. 

 

	 	•	 	 “Rating Agencies” means (1) each of Fitch, Moody’s and S&P; and (2) if any of Fitch,
Moody’s or S&P ceases to rate the Notes of this series or fails to make a rating of such Notes publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization” within
the meaning of Section 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company’s Board of Directors) as a replacement agency for Fitch, Moody’s or S&P, or all of them, as the case may
be. 

  

	 	•	 	 “Rating Event” means the rating on the Notes of this series is lowered by each of the three Rating
Agencies and the Notes of this series are rated below an Investment Grade Rating by each of the three Rating Agencies on any day during the period (which period shall be extended so long as the rating of the Notes of this series is under publicly
announced consideration for a possible downgrade by any of the Rating Agencies) commencing on the date of the first public notice of the occurrence of a Change of Control or the Company’s intention to effect a Change of Control and ending 60
days following consummation of such Change of Control. 

  

	 	•	 	 “S&P” means S&P Global Ratings, a division of S&P Global Inc., and its successors.

  

	 	•	 	 “Voting Stock” means, with respect to any specified “person” (as that term is used in
Section 13(d)(3) of the Exchange Act) as of any date, the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. 

 

	 	(10)	 The Notes shall not be convertible into shares of Common Stock of the Company or exchangeable for any other
securities. 

  

	 	(11)	 The Trustee shall be the Security Registrar and the Paying Agent. 

 

	 	(12)	 The amount of payments of principal of and any premium or interest on the Notes will not be determined with
reference to an index. 

  
 6 

	 	(13)	 The Notes shall be subject to the covenants and definitions set forth in the Indenture. 

 

	 	(14)	 The Notes will be issued only in fully registered form and the minimum initial purchase amounts of the Notes
shall be $2,000 and any whole multiples of $1,000 in excess thereof. 

  

	 	(15)	 The Notes shall be subject to the Events of Default specified in Section 701, paragraphs (i) through
(vii), of the Indenture. 

  

	 	(16)	 The portion of the principal amount of the Notes which shall be payable upon declaration of acceleration of
maturity thereof shall not be less than the principal amount thereof. 

  

	 	(17)	 The Notes shall be “Global Securities” as defined in the Indenture, and shall be deposited with, or
on behalf of, The Depository Trust Company, New York, New York, as Depositary, registered in the name of a nominee of the Depositary. So long as the Depositary or its nominee is the registered holder of any Global Security, the Depositary or its
nominee, as the case may be, shall be considered the sole Holder of the Notes represented by such Global Security for all purposes under the Indenture. The forms and terms of the Notes and the Trustee’s certificate of authentication shall be
substantially as set forth on Exhibit B hereto. The terms and provisions contained in the form of Notes set forth on Exhibit B hereto shall constitute, and are hereby expressly made, a part of the Indenture as supplemented by this
Officers’ Certificate and Company Order. 

  

	 	(18)	 The defeasance provisions set forth in Article IX of the Indenture shall apply to the Notes.

  

	 	(19)	 The following additional terms shall apply to the Notes: 

 

	 	(a)	 Further Issuances. The Company may, so long as no Event of Default has occurred, without the consent of
the Holders of the Notes, issue additional notes with the same terms as the Notes in accordance with the corporate authority existing at the time of such additional issuance, and such additional notes shall be considered part of the same series
under the Indenture as the Notes and will vote together with the Notes as one class on all matters with respect to the Notes, except that if the additional notes are not fungible for U.S. federal income tax purposes with the Notes, the additional
notes will be issued under a separate CUSIP number. 

  

	 	(b)	 Transfer and Exchange. 

 

	 	(i)	 The transfer and exchange of Global Securities or beneficial interests therein shall be effected through the
Depositary, in accordance with this Officers’ Certificate and Company Order (including applicable restrictions on transfer set forth herein, if any) and the procedures of the Depositary therefor. A transferor of a beneficial interest in a
Global Security shall deliver to the Security Registrar a written order given in accordance with the Depositary’s procedures containing information regarding the participant account of the Depositary to be credited with a beneficial interest in
the Global Security. The Security Registrar shall, in accordance with such instructions, instruct the Depositary to credit to the account of the Person specified in such instructions a beneficial interest in the Global Security and to debit the
account of the Person making the transfer the beneficial interest in the Global Security being transferred. Each Holder of a Security agrees to indemnify the Company and the Trustee against any liability that may result from the transfer, exchange
or assignment of such Holder’s Security in violation of any provision of the Indenture and/or applicable United States federal or state securities law. 

  
 7 

	 	(ii)	 Each Global Security shall bear the global security legend set forth on Exhibit A hereto.

  

	 	(20)	 The CUSIP number for the global Note is 91324PDQ2 and the ISIN number for the global Note is
US91324PDQ28. 

  

	B.	 Establishment of Forms of Securities Pursuant to Section 201 of Indenture.

 It is hereby established, pursuant to Section 201 of the Indenture, that the Global Security representing the Notes
shall be substantially in the form attached as Exhibit B hereto. 
  

	C.	 Order for the Authentication and Delivery of Securities Pursuant to Section 303 of the
Indenture. 

 It is hereby ordered pursuant to Section 303 of the Indenture that the Trustee authenticate, in the
manner provided by the Indenture, the Notes in the aggregate principal amount of $1,100,000,000 registered in the name of Cede & Co., which Notes have been heretofore duly executed by the proper officers of the Company and delivered
to you as provided in the Indenture, and to deliver said authenticated Notes to or on behalf of The Depository Trust Company on or before 10:30 a.m., Central Time, on December 17, 2018. 

 

	D.	 Other Matters. 

The Company has provided to the Trustee true and correct copies of resolutions adopted by the Board of Directors of the Company on
October 30, 2007, January 18, 2008 and February 8, 2017; such resolutions have not been further amended, modified or rescinded and remain in full force and effect except as otherwise provided therein; and such resolutions (together
with this Officers’ Certificate and Company Order) are the only resolutions or other action adopted by the Company’s Board of Directors or any committee thereof or by any officers of the Company relating to the offering and sale of the
Notes. 
 The undersigned Senior Vice President and Treasurer being an Authorized Representative as defined in the resolutions of the Board
of Directors of the Company adopted on October 30, 2007 certifies that (i) he has approved the terms of the Notes as set forth in this Officers’ Certificate and Company Order, (ii) he has approved and ratified the terms and form
of the Underwriting Agreement (the “Underwriting Agreement”) and the Pricing Agreement (the “Pricing Agreement”), each dated December 13, 2018, by and among the Company and J.P. Morgan Securities LLC, Citigroup Global Markets
Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC and U.S. Bancorp Investments, Inc., as representatives of the underwriters named in Schedule I to the Pricing Agreement, and (iii) he has approved and ratified the Indenture, all in
accordance with the authority of such officer pursuant to such resolutions. 
 The undersigned have read the pertinent sections of the
Indenture including the related definitions contained therein. The undersigned have examined the resolutions adopted by the Board of Directors of the Company. In the opinion of the undersigned, the undersigned have made such examination or
investigation as is necessary to enable the undersigned to express an informed opinion as to whether or not the conditions precedent to (i) the establishment of the Notes, (ii) the establishment of the form of the Notes and (iii) the
authentication of the Notes contained in the Indenture have been complied with. In the opinion of the undersigned, such conditions have been complied with. 

Simpson Thacher & Bartlett LLP, Dannette L. Smith, Senior Deputy General Counsel for the Company, and Hogan Lovells US LLP are
entitled to rely on this Officers’ Certificate and Company Order in connection with the opinions they are rendering pursuant to Sections 10(b), 10(c), and 10(d), respectively, of the Underwriting Agreement. 

[SIGNATURE PAGE TO FOLLOW] 

  
 8 

 IN WITNESS WHEREOF, the undersigned have executed this Officers’ Certificate and
Company Order this 17th day of December, 2018. 
  

	
	UNITEDHEALTH GROUP INCORPORATED
	
	 /s/ Peter M. Gill

	Peter M. Gill
	Senior Vice President and Treasurer
	
	 /s/ Dannette L. Smith

	Dannette L. Smith
	Secretary to the Board of Directors

 EXHIBIT A 

FORM OF LEGENDS 
 Global Security
Legend 
 THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO BELOW AND IS REGISTERED IN THE NAME
OF A DEPOSITARY OR A NOMINEE OF A DEPOSITARY. THIS NOTE IS EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER OF THIS NOTE
(OTHER THAN A TRANSFER OF THIS NOTE AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED
IN THE INDENTURE. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET,
NEW YORK, NEW YORK) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE
DEPOSITORY TRUST COMPANY AND ANY PAYMENT IS MADE TO CEDE & CO., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 EXHIBIT B 

FORM OF GLOBAL SECURITY 

[See attached.] 

 THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO BELOW AND IS
REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF A DEPOSITARY. THIS NOTE IS EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO
TRANSFER OF THIS NOTE (OTHER THAN A TRANSFER OF THIS NOTE AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN THE LIMITED
CIRCUMSTANCES DESCRIBED IN THE INDENTURE. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER
STREET, NEW YORK, NEW YORK) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
THE DEPOSITORY TRUST COMPANY AND ANY PAYMENT IS MADE TO CEDE & CO., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST
HEREIN. 
  

					
	REGISTERED	  	 UNITEDHEALTH GROUP

INCORPORATED
	  	$[            ]
	No. [    ]	  	 4.450% Notes due

December 15, 2048
	  	 CUSIP No. 91324PDQ2
 ISIN No.
US91324PDQ28

 UNITEDHEALTH GROUP INCORPORATED, a Delaware corporation (hereinafter called the “Company,”
which term includes any successor corporation under the Indenture referred to on the reverse side hereof), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of
[                ] Dollars ($[        ]) on December 15, 2048 (the “Stated Maturity”), and to pay
interest thereon from December 17, 2018 or from the most recent date to which interest has been paid or duly provided for, semi-annually in arrears on June 15 and December 15 in each year (each, an “Interest Payment
Date”), commencing June 15, 2019, and at maturity, at the rate of 4.450% per annum, until the principal hereof is paid or duly made available for payment. Interest on this Note shall be calculated on the basis of a 360-day year consisting of twelve 30-day months. The interest so payable and punctually paid or duly provided for on any Interest Payment Date shall, as provided in the
Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on the “Regular Record Date” for such interest, which shall be the June 1 or December 1
(whether or not a Business Day, as hereinafter defined) immediately preceding each such Interest Payment Date. Any such interest which is payable, but is not punctually paid or duly provided for, on any Interest Payment Date shall forthwith cease to
be payable to the registered Holder hereof on the relevant Regular Record Date by virtue of having been such Holder, and may be paid (i) to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of
business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to the Holder of this Note not less than 10 days prior to such Special Record Date, or (ii) in any other
lawful manner not inconsistent with the requirements of any securities exchange on which this Note may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment
pursuant to this clause (ii), such manner of payment shall be deemed practicable by the Trustee. In the event that any Interest Payment Date, the date of 

 
maturity or any date of repurchase or Redemption Date falls on a date that is not a Business Day, the related payment of principal and interest shall be postponed to the next succeeding Business
Day, but the payment made on such date will be treated as being made on the date that the payment was first due and the Holder of this Note shall not be entitled to any further interest or other payments with respect to such postponement.
“Business Day” shall mean any day other than a Saturday, a Sunday or a day on which banking institutions in New York, New York or Minneapolis, Minnesota are authorized or required by law, regulation or executive order to close. 

Payment of the principal of and the interest on this Note will be made at the corporate trust office of U.S. Bank National Association, in St.
Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts. The method of such payment shall be by wire transfer for a Note held in book-entry form or
at the option of the Company by check mailed to the Person entitled thereto as shown on the Security Register. Payment of the principal of and interest on this Note due at maturity will be made in immediately available funds upon presentation of
this Note. 
 Reference is hereby made to the further provisions of this Note set forth on the reverse side hereof, which further provisions
shall for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been
executed by or on behalf of the Trustee under the Indenture by the manual signature of one of its authorized signatories, this Note shall not be entitled to any benefits under the Indenture or be valid or obligatory for any purpose. 

[SIGNATURE PAGE TO FOLLOW] 

  
 2 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

Dated: December 17, 2018 
  

					
	UNITEDHEALTH GROUP INCORPORATED
		
	By:	 	
                     
                                        

		 	Name:	 	Peter M. Gill
		 	Title:	 	Senior Vice President and Treasurer
		
	Attest:	 	  

		 	Name:	 	Dannette L. Smith
		 	Title:	 	Secretary to the Board of Directors

 TRUSTEE’S CERTIFICATE OF 

AUTHENTICATION 
  

			
	 This is one of the Securities of the

series designated herein and issued
 pursuant to the
within-mentioned

	Indenture.
	
	Dated: December 17, 2018
	
	 U.S. BANK NATIONAL ASSOCIATION,

as Trustee

		
	By:	 	
                     
                                        

		 	Authorized Signatory

 UnitedHealth Group Incorporated 

4.450% Notes due December 15, 2048 

 [REVERSE SIDE OF NOTE] 

This Note is one of a duly authorized issue of securities of the Company (herein called the “Notes”) issued and to be issued in one
or more series under an indenture, dated as of February 4, 2008, between the Company and U.S. Bank National Association, as trustee (the “Trustee,” which term includes any successor trustee), as further supplemented by an
Officers’ Certificate and Company Order, dated December 17, 2018, pursuant to Section 301 of the indenture (together, the “Indenture”) between the Company and the Trustee, to which Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Notes, and the terms upon which the Notes are, and are to be,
authenticated and delivered. This Note is one of the series designated on the face hereof, limited in initial aggregate principal amount to $1,100,000,000; provided, however, that the Company may, so long as no Event of Default has occurred
and is continuing, without the consent of the Holders of the Notes of this series, issue additional notes with the same terms as the Notes of this series, and such additional notes shall be considered part of the same series under the Indenture as
the Notes of this series. 
 Optional Redemption 

This Note is redeemable, in whole or in part, at any time and from time to time before June 15, 2048 (six months prior to its Stated
Maturity), at the option of the Company at a Redemption Price equal to the greater of (i) 100% of the principal amount of this Note to be redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and
interest on this Note to be redeemed (excluding the portion of any such interest accrued to the Redemption Date) that would be due if this Note matured on June 15, 2048, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Yield (as defined below), plus 20 basis points, plus, in each case, accrued and unpaid interest thereon to,
but not including, the Redemption Date. 
 At any time on or after June 15, 2048 (six months prior to its Stated Maturity), this Note
will be redeemable, in whole or in part at any time and from time to time, at the option of the Company, at a Redemption Price equal to 100% of the principal amount of this Note to be redeemed plus accrued and unpaid interest thereon to, but not
including, the Redemption Date. 
 For this purpose, the following terms have the following meanings: 

 

	 	•	 	 “Treasury Yield” means, with respect to any Redemption Date, the rate per year equal to the semi-annual
equivalent yield to maturity or interpolated (on a day-count basis) yield to maturity of the applicable Comparable Treasury Issue, assuming a price for such Comparable Treasury Issue (expressed as a percentage
of its principal amount) equal to the applicable Comparable Treasury Price for such Redemption Date. 

  

	 	•	 	 “Comparable Treasury Issue” means the United States Treasury security selected by an Independent
Investment Banker appointed by the Trustee after consultation with the Company as having an actual or interpolated maturity comparable to the remaining term of this Note being redeemed (assuming that the Notes matured on June 15, 2048), or such
other maturity that would be utilized at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of this Note being redeemed.

  

	 	•	 	 “Comparable Treasury Price” means, with respect to any Redemption Date, (i) the average of the
Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations for such Redemption Date, or (ii) if the Trustee obtains fewer than four such Reference Treasury
Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. 

  
 4 

	 	•	 	 “Independent Investment Banker” means any of J.P. Morgan Securities LLC, Citigroup Global Markets Inc.,
Deutsche Bank Securities Inc., Mizuho Securities USA LLC, U.S. Bancorp Investments, Inc. or their respective successors or, if such firms are unwilling or unable to select the Comparable Treasury Issue, one of the remaining Reference Treasury
Dealers appointed by the Trustee after consultation with the Company. 

  

	 	•	 	 “Reference Treasury Dealer” means each of (i) J.P. Morgan Securities LLC, Citigroup Global Markets
Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC or their affiliates; (ii) any other primary U.S. Government securities dealer in the United States (a “Primary Treasury Dealer”) designated by, and not affiliated with,
J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC or U.S. Bancorp Investments, Inc.; provided, however, in the case of (i) and (ii), that if any of the foregoing shall cease to
be a Primary Treasury Dealer, the Company will appoint another Primary Treasury Dealer as a substitute for such entity; and (iii) any other Primary Treasury Dealer selected by the Trustee. 

 

	 	•	 	 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any
Redemption Date, the average, as determined by the Trustee, of the bid and asked prices for the applicable Comparable Treasury Issue (expressed, in each case, as a percentage of its principal amount) quoted in writing to the Trustee by such
Reference Treasury Dealer at 5:00 p.m. on the third Business Day preceding such Redemption Date. 

 A notice of redemption
may provide that it is subject to certain conditions that will be specified in the notice. If those conditions are not met, the redemption notice will be of no effect and the Company will not be obligated to redeem this Note. 

A partial redemption of the Notes may be effected on a pro rata basis (and in such manner as complies with applicable legal and stock exchange
requirements, if any) or in such method as the Trustee, in the exercise of its reasonable discretion, deems fair and appropriate. The Trustee may provide for the selection for redemption of portions in amounts of $1,000 or whole multiples of $1,000;
except that if all of the Notes of a Holder are to be redeemed, the entire outstanding amount of Notes held by such Holder, even if not a multiple of $1,000, shall be redeemed. 

Notice of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each Holder of the Notes to
be redeemed. 
 Unless any Note called for redemption shall not be paid upon surrender thereof for redemption, on and after the Redemption
Date interest will cease to accrue on the Notes or portions thereof called for redemption. 
 This Note will not be entitled to any sinking
fund. 
 Change of Control Offer 

If a Change of Control Triggering Event (as defined herein) occurs, unless the Company has exercised its option to redeem all the Notes of this
series, the Company shall be required to make an offer (a “Change of Control Offer”) to each Holder of the Notes of this series to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that
Holder’s Notes on the terms set forth herein. In a Change of Control Offer, the Company shall be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes of this series repurchased, plus accrued and unpaid
interest, if any, on the Notes of this series repurchased to, but not including, the date of repurchase (a “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event or, at the Company’s option,
prior to any Change of Control, 

  
 5 

 
but after public announcement of the transaction that constitutes or may constitute the Change of Control, a notice shall be transmitted to Holders of the Notes of this series describing the
transaction that constitutes or may constitute the Change of Control Triggering Event and offering to repurchase such Notes on the date specified in the notice, which date shall be no earlier than 30 days and no later than 60 days from the date such
notice is transmitted (a “Change of Control Payment Date”). The notice shall, if transmitted prior to the date of consummation of the Change of Control, state that the Change of Control Offer is conditioned on the Change of Control
Triggering Event occurring on or prior to the Change of Control Payment Date. 
 In order to accept the Change of Control Offer, the Holder
must deliver to the Paying Agent, at least five Business Days prior to the Change of Control Payment Date, this Note together with the form entitled “Election Form” (which form is annexed hereto) duly completed, or a telegram, telex,
facsimile transmission or a letter from a member of a national securities exchange, or the Financial Industry Regulatory Authority or a commercial bank or trust company in the United States setting forth: 

(i)    the name of the Holder of this Note; 

(ii)    the principal amount of this Note; 

(iii)    the principal amount of this Note to be repurchased; 

(iv)    the certificate number or a description of the tenor and terms of this Note; 

(v)    a statement that the Holder is accepting the Change of Control Offer; and 

(vi)    a guarantee that this Note, together with the form entitled “Election Form” duly completed, will be
received by the Paying Agent at least five Business Days prior to the Change of Control Payment Date. 
 Any exercise by a Holder of its
election to accept the Change of Control Offer shall be irrevocable. The Change of Control Offer may be accepted for less than the entire principal amount of this Note, but in that event the principal amount of this Note remaining outstanding after
repurchase must be equal to $2,000 or an integral multiple of $1,000 in excess thereof. 
 On the Change of Control Payment Date, the
Company shall, to the extent lawful: 
 (i)    accept for payment all Notes of this series or portions of such Notes
properly tendered pursuant to the Change of Control Offer; 
 (ii)    deposit with the Paying Agent an amount equal to
the Change of Control Payment in respect of all Notes of this series or portions of such Notes properly tendered; and 

(iii)    deliver or cause to be delivered to the Trustee the Notes of this series properly accepted together with an
Officers’ Certificate stating the aggregate principal amount of Notes of this series or portions of such Notes being repurchased. 

The Company shall not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third
party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party purchases all Notes of this series properly tendered and not withdrawn under its offer. In
addition, the Company shall not repurchase any Notes of this series if there has occurred and is continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a default in the payment of the Change of Control
Payment upon a Change of Control Triggering Event. 

  
 6 

 The Company shall comply with the requirements of Rule
14e-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in
connection with the repurchase of the Notes of this series as a result of a Change of Control Triggering Event. To the extent that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the
Notes of this series, the Company shall comply with those securities laws and regulations and shall not be deemed to have breached its obligations under the Change of Control Offer provisions of the Notes of this series by virtue of any such
conflict. 
 For purposes of the Change of Control Offer provisions of the Notes of this series, the following terms are applicable: 

 

	 	•	 	 “Change of Control” means the occurrence of any of the following: (1) the direct or indirect sale,
lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to any
person, other than the Company or a Subsidiary; (2) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the Company’s outstanding Voting Stock or other Voting Stock into which the
Company’s Voting Stock is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares; (3) the Company consolidates with, or merges with or into, any person, or any person consolidates with, or
merges with or into, the Company, in any such event pursuant to a transaction in which any of the Company’s outstanding Voting Stock or the Voting Stock of such other person is converted into or exchanged for cash, securities or other property,
other than any such transaction where the shares of the Company’s Voting Stock outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving person or any
direct or indirect parent company of the surviving person immediately after giving effect to such transaction; (4) the first day on which a majority of the members of the Company’s Board of Directors are not Continuing Directors; or
(5) the adoption of a plan relating to the Company’s liquidation or dissolution. Notwithstanding the foregoing, a transaction shall not be deemed to involve a Change of Control under clause (2) above if (i) the Company becomes a
direct or indirect wholly-owned subsidiary of a holding company and (ii)(A) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company’s Voting Stock immediately prior to that transaction or (B) immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or
indirectly, of more than 50% of the Voting Stock of such holding company. The term “person,” as used in this definition, has the meaning given thereto in Section 13(d)(3) of the Exchange Act. 

 

	 	•	 	 “Change of Control Triggering Event” means the occurrence of both a Change of Control and a Rating
Event. 

  

	 	•	 	 “Continuing Directors” means, as of any date of determination, any member of the Company’s Board
of Directors who (1) was a member of such Board of Directors on the date the Notes of this series were issued or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the
Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of the Company’s proxy statement in which such member was named as a nominee for
election as a director). 

  
 7 

	 	•	 	 “Fitch” means Fitch, Inc., and its successors. 

 

	 	•	 	 “Investment Grade Rating” means a rating equal to or higher than
BBB- (or the equivalent) by Fitch, Baa3 (or the equivalent) by Moody’s and BBB- (or the equivalent) by S&P, and the equivalent investment grade credit rating
from any replacement Rating Agency or Rating Agencies selected by the Company. 

  

	 	•	 	 “Moody’s” means Moody’s Investors Service, Inc., and its successors. 

 

	 	•	 	 “Rating Agencies” means (1) each of Fitch, Moody’s and S&P; and (2) if any of Fitch,
Moody’s or S&P ceases to rate the Notes of this series or fails to make a rating of such Notes publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization” within
the meaning of Section 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company’s Board of Directors) as a replacement agency for Fitch, Moody’s or S&P, or all of them, as the case may
be. 

  

	 	•	 	 “Rating Event” means the rating on the Notes of this series is lowered by each of the three Rating
Agencies and the Notes of this series are rated below an Investment Grade Rating by each of the three Rating Agencies on any day during the period (which period shall be extended so long as the rating of the Notes of this series is under publicly
announced consideration for a possible downgrade by any of the Rating Agencies) commencing on the date of the first public notice of the occurrence of a Change of Control or the Company’s intention to effect a Change of Control and ending 60
days following consummation of such Change of Control. 

  

	 	•	 	 “S&P” means S&P Global Ratings, a division of S&P Global Inc., and its successors.

  

	 	•	 	 “Voting Stock” means, with respect to any specified “person” (as that term is used in
Section 13(d)(3) of the Exchange Act) as of any date, the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. 

Miscellaneous Provisions 
 If an
Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 

The Indenture contains provisions for defeasance at any time of the Company’s obligations in respect of (i) the entire indebtedness
of this Note or (ii) certain restrictive covenants with respect to this Note, in each case upon compliance with certain conditions set forth therein. 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each series issued under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not less than a majority in aggregate principal amount of the
Securities of all series at the time Outstanding affected thereby. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the Securities of any series at the time Outstanding to waive
certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Notes issued upon the
registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 

  
 8 

 No reference herein to the Indenture and no provision of this Note or of the Indenture shall
alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Note, at the time, place and rate, and in the coin or currency, herein and in the Indenture
prescribed. 
 As provided in the Indenture and subject to certain limitations set forth therein and in this Note, the transfer of this Note
is registrable in the registry books of the Company, upon surrender of this Note for registration of transfer at the office or agency of the Company where the principal of (and premium, if any) and interest on this Note are payable, duly endorsed,
or accompanied by a written instrument of transfer in form satisfactory to the Company and the Trustee, duly executed by the Holder hereof or by his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized
denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
 The Notes of this
series are issuable only in fully registered form without coupons in minimal initial purchase amounts of $2,000 and whole multiples of $1,000 in excess thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes
of this series are exchangeable for a like aggregate principal amount of Notes of this series which are of like tenor for any authorized denomination, as requested by the Holder surrendering the same. 

No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to
cover any tax or other governmental charge payable in connection therewith, other than in certain cases provided in the Indenture. 
 Prior
to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this
Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 
 This Note shall be
governed by and construed in accordance with the laws of the State of New York, without regard to its conflicts of laws provisions. 
 All
capitalized terms used in this Note which are not defined herein shall have the meanings assigned to them in the Indenture. 

  
 9 

 ASSIGNMENT FORM 

I or we assign and transfer this Note to 
  

					
	  

	
	  

	(Print or type name, address and zip code of assignee or transferee)
	
	  

	
	(Insert Social Security or other identifying number of assignee or transferee)
	
	and irrevocably appoint
                                         
                    agent to transfer this Note on the books of the Issuer. The agent may substitute another to act for
him.

							
				
	Dated:                                    
                                         
	 	                            	 	Signed:	 	
                     
                                        

		 		 		 	 (Sign exactly as name appears on the other side of this
Note)

					
			
	Signature Guarantee:	 	  
	 	
		 	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor program reasonably acceptable to the Trustee)	 	

  
 10 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL SECURITY 

Initial Principal Amount at maturity of Global Security: [                ]
Dollars ($[        ]). 
 The following exchanges of a part of this Global Security for an interest in another
Global Security or for a certificated note, or exchanges of a part of another Global Security or certificated note for an interest in this Global Security, have been made: 
  

									
	 Date of Exchange
	  	 Amount of decrease

in

Principal Amount of

this Global Security
	  	 Amount of increase

in

Principal Amount of

this Global Security
	  	 Principal Amount of

this Global Security

following such

decrease

(or increase)
	  	 Signature of

authorized officer

of

Trustee or Note

Custodian

		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 11 

 ELECTION FORM 

TO BE COMPLETED ONLY IF THE HOLDER 

ELECTS TO ACCEPT THE CHANGE OF CONTROL OFFER 
  

 
 The undersigned
hereby irrevocably requests and instructs the Company to repurchase the within Note (or the portion thereof specified below), pursuant to its terms, on the Change of Control Payment Date specified in the Change of Control Offer, for the Change of
Control Payment specified in the within Note, to the undersigned,
                                        ,
at
                                         
                    (please print or typewrite name and address of the undersigned). 

For this election to accept the Change of Control Offer to be effective, the Company must receive, at the address of the Paying Agent set
forth below or at such other place or places of which the Company shall from time to time notify the Holder of the within Note, either (i) this Note with this “Election Form” form duly completed, or (ii) a telegram, telex,
facsimile transmission or a letter from a member of a national securities exchange or the Financial Industry Regulatory Authority or a commercial bank or a trust company in the United States setting forth (a) the name of the Holder of the Note,
(b) the principal amount of the Note, (c) the principal amount of the Note to be repurchased, (d) the certificate number or description of the tenor and terms of the Note, (e) a statement that the option to elect repurchase is
being exercised, and (f) a guarantee stating that the Note to be repurchased, together with this “Election Form” duly completed will be received by the Paying Agent five Business Days prior to the Change of Control Payment Date. The
address of the Paying Agent is U.S. BANK NATIONAL ASSOCIATION, 60 Livingston Avenue, EP-MN-WS3C, St. Paul, MN 55107-2292. 

If less than the entire principal amount of the within Note is to be repurchased, specify the portion thereof (which principal amount must be
$2,000 or an integral multiple of $1,000 in excess thereof) which the Holder elects to have repurchased: $        . 

  
 12EX-10.1

 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of December 16, 2018 by and between Acadia
Management Company, Inc., a Delaware corporation (the “Company”), and Debra Osteen (“Executive”). This Agreement shall become binding upon the execution hereof and shall become effective upon December 17, 2018 (the
“Effective Date”). 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

1.    Employment; Employment Period. The Company shall employ Executive, and Executive hereby accepts employment
with the Company, upon the terms and conditions set forth in this Agreement for the period beginning on the Effective Date and ending on December 31, 2020 (the “Employment Period”). Notwithstanding the foregoing, Executive’s
employment hereunder may be earlier terminated in accordance with (and subject to) Section 4 hereof. The place of employment of Executive shall be the principal executive offices and corporate headquarters of the Company
and Acadia Healthcare Company, Inc., a Delaware corporation (“Acadia”), which, during the Employment Period, shall be located in Williamson County, Tennessee. Executive will spend substantially all Executive’s business time in
the Williamson County, Tennessee corporate office (other than while traveling for business purposes). 

2.    Position and Duties. 

(a)    Position; Responsibilities. During the Employment Period, Executive shall serve as the Chief Executive
Officer of Acadia, and shall have the normal duties, responsibilities, functions and authority of a chief executive officer in similarly sized companies that are not inconsistent with Executive’s position as Chief Executive Officer, subject to
the power and authority of the board of directors (the “Board”) of Acadia, to expand or limit such duties, responsibilities, functions and authority within the scope of duties, responsibilities, functions and authority associated
with the position of Chief Executive Officer and to overrule actions of officers of the Company. Commencing with the first annual meeting of stockholders held after the Effective Date, Acadia shall cause the nominating and corporate governance
committee of the Board (the “Nominating Committee”) to nominate Executive to serve as a member of the Board each year Executive’s term of Board service is to be slated for reelection to the Board. If the Company’s
stockholders vote in favor of the Nominating Committee’s nomination of Executive to serve as a member of the Board, Executive agrees to serve in such capacity. During the Term, Executive agrees to serve on all other boards of directors of
Subsidiaries of the Company or its affiliates and Executive agrees that any such board service shall be without additional compensation. 

(b)    Reporting; Performance of Duties. Executive shall report to the Board and all employees of Acadia and its
Subsidiaries shall report to Executive or her designee(s). Executive shall devote substantially all of her business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity) to the business and
affairs of Acadia and the Subsidiaries. So long as Executive is employed by the Company, Executive shall not, without the prior written consent or approval of the Board, perform other services for 

  
 1 

 compensation. Notwithstanding the foregoing, nothing herein shall preclude Executive from (i) serving,
with the prior written consent of the Board, as a member of the boards of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of for-profit companies or businesses which are not directly competitive with the
Company or any Subsidiary (provided that the prior written consent of the Board shall not be required for Executive to serve as a member of the boards of directors or advisory boards (or their equivalents) of the companies listed on Exhibit
A, (ii) engaging in charitable activities and community affairs (including serving as a member of the boards of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of not-for-profit, charitable or
community organizations which are not directly competitive with the Company or any Subsidiary); and (iii) managing Executive’s personal and legal affairs and her passive personal investments; provided, however, the activities set out in
clauses (i) and (ii) above shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the performance of her duties and responsibilities hereunder. For the avoidance of doubt, so long as Executive is
employed by the Company, Executive shall not provide any services to any company or business that is directly competitive with Acadia or the Subsidiaries (whether for-profit or not-for-profit) without the prior written consent of the Board. 

3.    Compensation and Benefits. 

(a)    Base Salary. During the Employment Period, Executive’s base salary shall be no less than $900,000 per
annum, subject to increase by the Board or Acadia’s Compensation Committee (the “Compensation Committee”) in its sole discretion on an annual basis (as increased from time to time, the “Base Salary”), which
salary shall be payable by the Company in regular installments in accordance with the Company’s general payroll practices (as in effect from time to time). The Base Salary for any partial year during the Employment Period will be based upon the
actual number of days elapsed in such year. 
 (b)    Business Expenses. During the Employment Period, the
Company shall reimburse Executive in the calendar year in which they are incurred for all reasonable out-of- pocket business expenses incurred by her in the course of performing her duties and responsibilities under this Agreement which are
consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company’s requirements with respect to reporting and documentation of such expenses. 

(c)    Bonus. In addition to the Base Salary, during each calendar year of the Employment Period beginning with the
year ending December 31, 2019, Executive will be eligible to earn a target annual cash bonus of not less than 100% of the Base Salary (the “Target Bonus”) and up to a maximum cash bonus determined in accordance with the
Company’s annual bonus plan for senior executives, if and only if Executive, Acadia and the Subsidiaries achieve the performance criteria specified by the Board or the Compensation Committee for such year, as determined by the Board or the
Compensation Committee in its sole discretion. The performance criteria for any particular year shall be set by the Board or the Compensation Committee no later than ninety (90) days after the commencement of the relevant year. Unless otherwise
agreed to by Executive, any such bonus amount for any year shall be earned (if awarded) on the last day of such year and paid by the Company in the calendar year following the calendar year to which such bonus has been earned and no later than the
earlier of (x) the date that is ten (10) business 

  
 2 

 days after the Company’s receipt of its audited financial statements for the calendar year with respect
to which such bonus has been earned and (y) December 31 of the calendar year following such year with respect to which such bonus has been earned. 

(d)    Long-Term Incentive Compensation. Executive will be entitled to a long- term incentive award in 2019 that
will have a target value equal to not less than $3.2 million (such value to be determined on the same basis as the Committee values such awards generally) and shall be in a form and on terms consistent with the long-term incentive awards for
other senior executives of the Company granted in 2019. Thereafter, the Executive shall be eligible for annual grants of equity awards or other long-term incentive awards in amounts as determined by the Committee and on terms and conditions
comparable to the Company’s other senior executives. 
 (e)    Benefits. In addition to (but without
duplication of) the Base Salary and any bonuses payable to Executive pursuant to this Section 3, Executive shall be entitled to participate at her sole discretion in all of the Company’s employee benefit programs for
which senior executive employees of the Company are generally eligible. 
 (f)    Make Whole Compensation.
Promptly after the commencement of Executive’s employment with the Company, the Company will pay or provide Executive with the payments and benefits set forth on Schedule 1 hereto. The amounts described in this
Section 3(f) shall be in addition to the payments and benefits specified in Section 4 below. 

(g)    Relocation. 

(i)    Travel Expenses. During the twelve-month period following the Effective Date (or, if earlier,
Executive’s permanent relocation to the Nashville, Tennessee metropolitan area (the “Relocation Area”) (such period, the “Relocation Period”), the Company will reimburse Executive for the rent paid by Executive
for an apartment in or around the Relocation Area, and reasonable related living expenses including utilities, telephone, parking, food, leased automobile, automobile fuel and maintenance up to an aggregate amount of $8,000 per month (collectively,
the “Living Expenses”), subject to the Company’s requirements with respect to reporting and documentation of such expenses. To the extent that the reimbursement of any Living Expenses results in taxable income to Executive, the
Company shall pay to Executive an additional amount (the “Living Expense Gross-Up”) such that the net after-tax proceeds to Executive of the reimbursement of her Living Expenses and the Living Expense Gross-Up (at her then-current
combined state and federal marginal income tax rates) is equal to Executive’s reimbursable Living Expenses. The Company will pay or reimburse (in each case on an after-tax basis) reasonable travel expenses to and from her current residence one
round trip per week, first-class fare. The Company shall pay the amounts contemplated by this Section 3(g)(i) within thirty (30) days following the date of Executive’s submission of the applicable expense. 

  
 3 

 (ii)    Relocation. Executive agrees and
understands that Executive shall be required to permanently relocate to the Relocation Area within 12 months following the Effective Date (the “Relocation Requirement”). The Company shall pay directly or reimburse Executive for all
moving, packing, shipping, travel, storage, broker fees, closing costs, new loan financing fees, insurance, and other relocation expenses incurred by her in the course of her relocation to the Relocation Area up to an aggregate amount of $225,000
(collectively, the “Relocation Expenses”), subject to the Company’s requirements with respect to reporting and documentation of such expenses, and to the extent that the reimbursement of any Relocation Expenses results in
taxable income to Executive, the Company shall pay to Executive an additional amount (the “Relocation Gross-Up”) such that the net after-tax proceeds to Executive of the reimbursement of her Relocation Expenses and the Relocation
Gross-Up (at her then-current combined state and federal marginal income tax rates) is equal to Executive’s reimbursable Relocation Expenses. In addition, in the event of Executive’s termination of employment within the six (6) month
period following the Company failing to extend or renew the Employment Period on substantially similar terms (a “Non-Renewal”), the Company shall pay Executive a lump sum cash payment in an amount equal to $100,000, payable within
thirty (30) days following the date of such termination of employment. 
 (h)    Counsel Fees. Upon
presentation of appropriate documentation, the Company shall pay Executive’s reasonable counsel fees incurred in connection with the negotiation and documentation of this Agreement in an amount up to $35,000, and matters related hereto, payable
within thirty (30) days following the execution of this Agreement. 
 4.    Termination. 

(a)    Termination. The Employment Period shall terminate automatically and immediately upon Executive’s
resignation for any reason (whether with Good Reason or without Good Reason), Executive’s death or becoming Disabled, or upon the termination of Executive’s employment by the Company (through action by the Board) for any reason (whether
for Cause or without Cause). The date on which Executive ceases to be employed by the Company is referred to herein as the “Termination Date.” 

(b)    Termination without Cause or with Good Reason. If the Employment Period is terminated by the Company without
Cause or by Executive with Good Reason, then Executive shall be entitled to receive: 

(i)    Executive’s unpaid Base Salary through the Termination Date (payable in accordance with
Section 3(a)) and any accrued but unpaid cash bonus with respect to a completed performance period; 

(ii)    payment in respect of any unused paid time off and sick pay of Executive in such amounts as have
accrued as of the Termination Date in accordance with the Company’s policies with respect thereto as in effect during the Employment Period, and reimbursement of any business expenses incurred by Executive but not reimbursed prior to the
Termination Date in accordance with and reimbursable under the terms of the Company’s policies with respect thereto 

  
 4 

 
as in effect on the Termination Date (in each case, payable in a lump sum within ten (10) business days after the Termination Date) and all other payments, benefits or fringe benefits to
which Executive shall be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement; 

(iii)    an amount equal to the sum of Executive’s Base Salary and Target Bonus, payable in
substantially equal installments in accordance with the Company’s general payroll practices (as in effect from time to time) during the 12-month period following the Termination Date; 

(iv)    an amount equal to the actual annual cash bonus amount to which Executive would be entitled under
Section 3(c) with respect to the calendar year in which the Termination Date occurs, determined based on achievement of the performance objectives specified in Executive’s bonus plan for such year (with any subjective
performance criteria deemed achieved at target), as determined by the Board or the Compensation Committee consistent with other senior executives of the Company, which amount shall be prorated based on the actual number of days elapsed in such year
prior to the Termination Date (payable at the same time it would have been paid pursuant to Section 3(c)); and 

(v)    an amount equal to the after-tax cost of the premiums for continued health and dental insurance for
Executive and/or Executive’s dependents in accordance with the Consolidated Budget Reconciliation Act of 1985 (“COBRA”) for the period commencing on the Termination Date and ending on the eighteen-month anniversary of the
Termination Date (payable in monthly installments during and concurrently with Executive’s COBRA period). 
 Notwithstanding the foregoing, Executive
shall be entitled to receive such payments described in Section 4(b)(iii) through 4(b)(vii) only so long as Executive has not breached any of the provisions of Sections 5, 6 and 7 hereof, and all
amounts payable and benefits or additional rights provided pursuant to Section 4(b)(iii) through 4(b)(vii) shall only be payable if Executive delivers to the Company and does not revoke a general release of claims in
favor of the Company in substantially the form attached on Exhibit B hereto; such release shall be executed and delivered (and no longer subject to revocation, if applicable) within sixty (60) days following Executive’s termination
(the “Release Requirement”). 
 (c)    Termination by Death or Disability. If the Employment
Period is terminated due to Executive’s death or becoming Disabled, then Executive (or her estate or beneficiary) shall be entitled to receive: 

(i)    Executive’s unpaid Base Salary through the Termination Date (payable in accordance with
Section 3(a)) and any accrued but unpaid cash bonus with respect to a completed performance period; 

  
 5 

 (ii)    payment in respect of any unused paid time off
and sick pay of Executive in such amounts as have accrued as of the Termination Date in accordance with the Company’s policies with respect thereto as in effect during the Employment Period, and reimbursement of any business expenses incurred
by Executive but not reimbursed prior to the Termination Date in accordance with and reimbursable under the terms of the Company’s policies with respect thereto as in effect on the Termination Date (in each case, payable in a lump sum within
ten (10) business days after the Termination Date) and all other payments, benefits or fringe benefits to which Executive shall be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or
program or grant or this Agreement; 
 (iii)    an amount equal to the actual annual cash bonus amount to
which Executive would be entitled under Section 3(c) with respect to the calendar year in which the Termination Date occurs, determined based on achievement of the performance objectives specified in Executive’s bonus
plan for such year (with any subjective performance criteria deemed achieved at target), as determined by the Board or the Compensation Committee consistent with other senior executives of the Company, which amount shall be prorated based on the
actual number of days elapsed in such year prior to the Termination Date (payable at the same time it would have been paid pursuant to Section 3(c)); and 

(iv)    an amount equal to the after-tax cost of the premiums for continued health and dental insurance for
Executive and/or Executive’s dependents in accordance with COBRA for the period commencing on the Termination Date and ending on the earliest of (A) the date on which Executive’s COBRA period terminates or expires, (B) six (6)
months after the Termination Date, and (C) the date on which Executive becomes eligible for long-term disability benefits under any long-term disability program sponsored by the Company (payable in monthly installments during and concurrently
with Executive’s COBRA period); provided that if Executive’s COBRA period is terminated prior to expiration of the period commencing on the Termination Date and ending on the earlier of (I) the date on which Executive becomes eligible
for long-term disability benefits under any long-term disability program sponsored by the Company, and (II) six (6) months after the Termination Date (such period, the “Disability Severance Period”), then Executive shall be
entitled to continue to receive an amount equal to the cost of the premiums for continued health and dental insurance for Executive and/or Executive’s dependents in accordance with COBRA (assuming such continued insurance coverage remained
available at the same monthly cost) payable in monthly installments during the period commencing on the date of such termination or expiration and ending on the date on which the Disability Severance Period expires. 

In addition, if the Employment Period is terminated due to Executive’s becoming Disabled (but, for the avoidance of doubt, not due to her death), then
Executive (or her estate or beneficiary) shall be entitled to receive, during the Disability Severance Period, continued installment payments of Executive’s Base Salary as in effect on the Termination Date, which shall be payable over the
Disability Severance Period in regular installments in accordance with the Company’s general payroll practices as in effect on the Termination Date, but in no event less frequently than monthly. 

  
 6 

 (d)    Other Termination. If the Employment Period is terminated
(i) by the Company for Cause, or (ii) by Executive’s resignation without Good Reason, then the Company shall pay Executive (A) Executive’s unpaid Base Salary through the Termination Date (payable in accordance with
Section 3(a)) and (B) any bonus amount under Section 3(c) to which Executive is entitled determined by reference to the calendar year that ended on or prior to the Termination Date (payable at
the same time it would have been paid pursuant to Section 3(c)) and all other payments, benefits or fringe benefits to which Executive shall be entitled under the terms of any applicable compensation arrangement or benefit,
equity or fringe benefit plan or program or grant or this Agreement. 
 (e)    Treatment of 2019 and 2020 Equity
Awards. If the Employment Period is terminated by the Company without Cause, by Executive with Good Reason, as a result of Executive’s death or Disability, or by the Executive within six months of a Non-Renewal (a “Qualifying
Termination”), annual equity and equity-based awards granted to Executive in 2019 and 2020 (the “2019 and 2020 Awards”) shall be treated as set forth below, subject to Executive’s satisfaction of the Release
Requirement: (i) the time vesting component(s) of the 2019 and 2020 Awards will be deemed satisfied upon a Qualifying Termination; and (ii) 2019 and 2020 Awards subject to performance-based vesting will remain outstanding and eligible to vest
based on actual achievement of the applicable performance conditions, subject to the terms and conditions set forth in the applicable award agreement and/or governing documentation. 

(f)    Continuation of Benefits. Upon any termination of employment, whether voluntary or otherwise, Executive
shall have the option to elect health insurance coverage for himself, her spouse and her eligible dependents during the period commencing on the end of the statutory COBRA period, if any (provided that Executive validly elected COBRA continuation
coverage), until the earlier of the date on which Executive (A) is eligible to participate in another health benefit plan (including, without limitation, a plan sponsored by a then current or former employer of Executive’s or
Executive’s spouse, other than a plan that provides for “excepted benefits” as defined under section 733(c) of the Employee Retirement Income Security Act of 1974) or (B) becomes eligible for Medicare. Such coverage will be
provided for by the Company (or any successor to the Company, whether by operation of law or otherwise) in accordance with applicable law, and Executive shall pay premiums consistent with other senior executive employees of the Company (or any
successor to the Company, whether by operation of law or otherwise). Executive agrees to take all required actions and provide any requested personal medical history and information, in accordance with the applicable policy application and medical
underwriting process. Nothing in this Section 4(f) shall decrease or reduce Executive’s rights or entitlements under Sections 4(b)(v) or 4(c)(iv) hereof. 

(g)    No Mitigation. Executive is under no obligation to mitigate damages or the amount of any payment provided
for under this Section 4 by seeking other employment or otherwise. 

  
 7 

 (h)    Right of Offset. The Company may offset any bona fide
obligations that Executive owes Acadia or any of the Subsidiaries (which for the avoidance of doubt shall not include any unliquidated obligations or obligations to the extent Executive disputes in good faith the nature or amount thereof) against
any amounts the Company or any of the Subsidiaries owes Executive hereunder; provided that, notwithstanding the foregoing or any other provision of this Agreement to the contrary, in no event shall any payment under this Agreement that constitutes
“deferred compensation” for purposes of Code Section 409A be subject to offset, counterclaim or recoupment by any other amount unless otherwise permitted by Code Section 409A. 

(i)    Section 409A Compliance. 

(i)    The intent of the parties is that payments and benefits under this Agreement comply with Internal
Revenue Code Section 409A and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in
compliance therewith. In no event whatsoever shall Acadia or any of the Subsidiaries be liable for any additional tax, interest or penalty that may be imposed on Executive by Code Section 409A or damages for failing to comply with Code
Section 409A. 
 (ii)    A termination of employment shall not be deemed to have occurred for
purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code
Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment,” “termination of the Employment Period” or like terms shall mean “separation
from service.” 
 (iii)    All expenses or other reimbursements under this Agreement shall be made
on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by Executive (provided that if any such reimbursements constitute taxable income to Executive, such reimbursements shall be paid no later
than March 15th of the calendar year following the calendar year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses
eligible for reimbursement in any other taxable year. 
 (iv)    For purposes of Code Section 409A,
Executive’s right to receive any installment payment pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. 

(v)    Whenever a payment under this Agreement specifies a payment period with reference to a number of
days (e.g., “payment shall be made within fifteen (15) days following the Termination Date”), the actual date of payment within the specified period shall be within the sole discretion of the Company. 

  
 8 

 (vi)    Notwithstanding any other payment schedule
provided herein to the contrary, if Executive is deemed on the Termination Date to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then any payment that is considered deferred compensation
under Code Section 409A payable on account of a “separation from service” shall be made on the date which is the earlier of (i) the expiration of the six (6)-month period measured from the date of such “separation from
service” of Executive and (ii) the date of Executive’s death (the “Delay Period”) to the extent required under Code Section 409A. Upon the expiration of the Delay Period, all payments delayed pursuant to the
immediately preceding sentence (whether they otherwise would have been payable in a single sum or in installments in the absence of such delay) shall be paid to Executive in a lump sum, and all remaining payments due under this Agreement shall be
paid or provided in accordance with the normal payment dates specified for them herein. In addition, if Executive is a “specified employee,” to the extent that welfare benefits to be provided to Executive pursuant to this Agreement are not
“disability pay,” “death benefit” plans or non-taxable medical benefits within the meaning of Treasury Regulation Section 1.409A-1(a)(5) or other benefits not considered nonqualified deferred compensation within the meaning
of that regulation, such provision of benefits shall be delayed until the end of the Delay Period. Notwithstanding the foregoing, to the extent that the previous sentence applies to the provision of any ongoing health or welfare benefits that would
not be required to be delayed if the premiums were paid by Executive, Executive shall pay the full cost of the premiums for such benefits during the Delay Period and the Company shall pay Executive an amount equal to the amount of such premiums paid
by Executive during the Delay Period within ten (10) days after the end of Delay Period. 
 (j)    Upon any
termination of Executive’s employment with the Company, Executive shall promptly resign, and shall be automatically deemed to have resigned without the requirement of any further action, from any position as an officer, director or fiduciary of
Acadia and the Company and their respective Affiliates (including, without limitation the Board of Acadia). Executive agrees to execute any additional documentation reasonably requested by the Company to implement any such resignation contemplated
herein. 
 5.    Confidential Information. 

(a)    Protection of Confidential Information. Executive acknowledges that the continued success of Acadia and the
Subsidiaries depends upon the use and protection of a large body of confidential and proprietary information. All of such confidential and proprietary information now existing or to be developed in the future will be referred to in this Agreement as
“Confidential Information.” Confidential Information will be interpreted broadly to include, without limitation, all information that is (i) related to Acadia’s or the Subsidiaries’ (including any of their
predecessors’ prior to being acquired by the Company) current or potential business and (ii) is not generally or publicly known (including, without specific limitation, the information, observations and data concerning (A) acquisition
opportunities in or reasonably related to Acadia’s or the Subsidiaries’ business or industry, (B) identities and requirements of, contractual arrangements with and other information regarding Acadia’s or the Subsidiaries’
employees (including personnel files and other information), suppliers, distributors, customers, independent contractors, third-party payors, providers or other business relations and their 

  
 9 

 
confidential information, including, without limitation, patient records, medical histories and other information concerning patients (including, without limitation, all “Protected Health
Information” within the meaning of the Health Insurance Portability and Accountability Act), and (C) internal business information and intellectual property of every kind and description of Acadia and the Subsidiaries). Executive agrees
that during the Employment Period and for five (5) years thereafter, she shall not disclose to any unauthorized person or use for her own account any of such Confidential Information, whether or not developed by Executive, without the
Board’s prior written consent, unless and to the extent that any Confidential Information (i) was known to Executive prior to the negotiation of this Agreement or the Employment Period from a source (other than Acadia, the Subsidiaries or
any of their respective agents) that, to the knowledge of Executive, was not prohibited from disclosing such information by a legal, contractual or fiduciary obligation to Acadia or any of the Subsidiaries, (ii) becomes generally known to and
available for use by the public other than as a result of Executive’s acts or omissions to act or (iii) is required to be disclosed pursuant to any applicable law or court order. 

(b)     Use of Others’ Confidential Information. During the Employment Period, Executive shall not use or
disclose any confidential information or trade secrets, if any, of any former employers or any other Person to whom Executive has an obligation of confidentiality. If at any time during her employment with the Company, Executive believes she is
being asked to engage in work that will, or will be likely to, jeopardize any confidentiality or other obligations Executive may have to former employers, then Executive shall immediately advise the Board so that Executive’s duties can be
modified appropriately. 
 (c)     Third-Party Information. Executive understands that Acadia and the
Subsidiaries will receive from third parties confidential or proprietary information (“Third-Party Information”) subject to a duty on Acadia’s and the Subsidiaries’ part to maintain the confidentiality of
such information and to use it only for certain limited purposes. During the Employment Period and thereafter, and without in any way limiting the provisions of Section 5(a) above, Executive will hold Third-Party Information in the strictest
confidence and will not disclose to anyone (other than personnel of Acadia or the Subsidiaries who need to know such information in connection with their work for Acadia or the Subsidiaries) or use, except in connection with her work for Acadia or
the Subsidiaries, Third-Party Information unless expressly authorized by the Board in writing. 
 (d)    
Whistleblower Protection. Notwithstanding anything to the contrary contained herein, no provision of this Agreement shall be interpreted so as to impede Executive (or any other individual) from reporting possible violations of federal law or
regulation to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures under the whistleblower
provisions of federal law or regulation. Executive does not need the prior authorization of Acadia or any of the Subsidiaries to make any such reports or disclosures and Executive shall not be not required to notify the Acadia or any of the
Subsidiaries that such reports or disclosures have been made. 
 (i)     Trade Secrets. 18 U.S.C. § 1833(b)
provides: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government
official, 

  
 10 

 
either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed
by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a
suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. 

6.     Ownership of Intellectual Property, Inventions and Patents. Executive acknowledges that all discoveries,
concepts, ideas, inventions, innovations, improvements, developments, methods, processes, programs, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information)
and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not patentable) which relate to Acadia’s or the Subsidiaries’ actual or anticipated business,
research and development or existing or future products or services and which are conceived, developed, contributed to, made or reduced to practice by Executive (whether alone or jointly with others) while employed by Acadia or the Subsidiaries
after the date of this Agreement, including any of the foregoing that constitutes any proprietary information or records (“Work Product”), belong to Acadia or such Subsidiary. Any copyrightable work prepared in whole or in part by
Executive in the course of her work for any of the foregoing entities shall be deemed a “work made for hire” to the maximum extent permitted under copyright laws, and Acadia or such Subsidiary shall own all rights therein. To the extent
any such copyrightable work is not a “work made for hire,” Executive hereby assigns and agrees to assign to Acadia or such Subsidiary all right, title and interest, including, without limitation, copyright, in and to such copyrightable
work. Executive shall promptly disclose such Work Product to the Board and, at the Company’s expense, perform all actions reasonably requested by the Board (whether during or after the Employment Period) to establish and confirm such ownership
by Acadia or such Subsidiary (including, without limitation, execution and delivery of assignments, consents, powers of attorney and other instruments). 

7.    Non-Compete; Non-Solicit. 

(a)    Non-Compete. In further consideration of the compensation to be paid to Executive hereunder, Executive
acknowledges that during the course of her employment with the Company she has and shall become familiar with Acadia’s and the Subsidiaries’ trade secrets and with other Confidential Information concerning Acadia and the Subsidiaries and
that her services have been and shall be of special, unique and extraordinary value to Acadia and the Subsidiaries, and, therefore, Executive agrees that, during the Employment Period and for a period thereafter of 12 months (the “Noncompete
Period”), she shall not (i) directly or indirectly own any interest in, manage, control, participate in, consult with, render services for, or in any manner engage in any business that derives at least 25% of its gross revenue from
(A) the business of providing behavioral healthcare and/or related services, or (B) any other material business in which Acadia or any of its Subsidiaries planned to be engaged in on or after such date of which the Executive has or should
have had actual knowledge, or (ii) directly or indirectly manage, control, participate in, consult with or render services specifically with 

  
 11 

 
respect to any unit, division, segment or subsidiary of any other business that engages in or otherwise competes with (or was organized for the purpose of engaging in or competing with) the
business of providing behavioral healthcare and/or related services (provided that, this clause (ii) shall not be construed to prohibit Executive from directly or indirectly owning any interest in, managing, controlling, participating in,
consulting with, rendering services for, or in any manner engaging in any business activities with or for such business generally and, for the avoidance of doubt, not specifically with respect to such unit, division, segment or subsidiary), in each
case, within any geographical area in which Acadia and the Subsidiaries engage in such businesses; provided that Executive shall not be subject to the restrictions set forth in this Section 7(a) if the Employment Period is
terminated by the Company without Cause or by Executive with Good Reason and for so long as the Company is in breach of its obligations under Section 4(b) and such breach is not the subject of a good faith dispute between
the Company and Executive. For purposes of this Agreement, the term “participate in” shall include, without limitation, having any direct or indirect interest in any Person, whether as a sole proprietor, owner, stockholder, partner, joint
venturer, creditor or otherwise, or rendering any direct or indirect service or assistance to any individual, corporation, partnership, joint venture and other business entity (whether as a director, officer, manager, supervisor, employee, agent,
consultant or otherwise). Nothing herein shall prohibit Executive from being a passive owner of not more than 2% of the outstanding stock of any class of a corporation which is publicly traded, so long as Executive has no active participation in the
business of such corporation. 
 (b)    Non-Solicit. During the Employment Period and for a period thereafter of
12 months (the “Nonsolicit Period”), Executive shall not directly or indirectly through another Person (other than on behalf of Acadia and the Subsidiaries) (i) induce or attempt to induce any employee or independent contractor
of Acadia or the Subsidiaries to leave the employ or services of Acadia or the Subsidiaries, or in any way willfully interfere with the relationship between Acadia and the Subsidiaries and any employee or independent contractor thereof,
(ii) hire or seek any business affiliation with any person who was an employee or independent contractor of Acadia or the Subsidiaries at any time during the twelve (12) months prior to the Termination Date or (iii) willfully induce
or attempt to induce any customer, supplier, licensee, licensor or other business relation of Acadia or any Subsidiary to cease doing business with Acadia or such Subsidiary or willfully interfere with the relationship between any such customer,
supplier, licensor or other business relation and Acadia or any Subsidiary; provided that Executive shall not be subject to the restrictions set forth in this Section 7(b). 

(c)     Non-Disparagement. Without limiting any other obligation of Executive pursuant to this Agreement,
Executive hereby covenants and agrees that, except as may be required by applicable law, Executive shall not make any statement, written or verbal, in any forum or media, or take any other action in disparagement of Acadia or any of its
Subsidiaries, during the Employment Period and for a period of five (5) years thereafter (the “Non- Disparagement Period”). Without limiting any other obligation of Acadia and its Subsidiaries pursuant to this Agreement,
Acadia hereby covenants and agrees that, except as may be required by applicable law, Acadia shall direct its executive officers and members of its board of directors (and use commercially reasonable efforts to obtain compliance with such direction)
not to make any statement, written or verbal, in any forum or media, or take any other action in disparagement of Executive, during the Employment Period and the Non-Disparagement Period. This Section 7(c) will not be violated by
(i) truthful statements required to be made by law or legal process, or (ii) internal statements in connection with providing services to Acadia and its Subsidiaries. 

  
 12 

 (d)    Blue-Pencil. If, at the time of enforcement of
Section 5 or 6 or this Section 7, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration,
scope or area reasonable under such circumstances shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum duration, scope and area permitted by
law. Executive hereby acknowledges and represents that she has either consulted with independent legal counsel regarding her rights and obligations under this Agreement or knowingly and voluntarily waived the opportunity to do so and that she fully
understands the terms and conditions contained herein. 
 (e)    Additional Acknowledgments.
Executive acknowledges that the provisions of Sections 5 and 6 and this Section 7 are in consideration of Executive’s employment with the Company and other good and valuable consideration as set forth in
this Agreement. In addition, Executive agrees and acknowledges that the restrictions contained in Sections 5 and 6 and this Section 7 do not preclude Executive from earning a livelihood, nor do they
unreasonably impose limitations on Executive’s ability to earn a living. In addition, Executive acknowledges (x) that the business of Acadia and the Subsidiaries will be conducted throughout the United States and its territories and
beyond, (y) notwithstanding the state of organization or principal office of Acadia or any of the Subsidiaries or facilities, or any of their respective executives or employees (including Executive), it is expected that Acadia and the
Subsidiaries will have business activities and have valuable business relationships within its industry throughout the United States and its territories and beyond, and (z) as part of Executive’s responsibilities, Executive will be
traveling throughout the United States and other jurisdictions where Acadia and the Subsidiaries conduct business during the Employment Period in furtherance of the Company’s business relationships. Executive agrees and acknowledges that the
potential harm to Acadia and the Subsidiaries of the non-enforcement of any provision of Sections 5 and 6 and this Section 7 outweighs any potential harm to Executive of its enforcement by injunction or
otherwise. Executive acknowledges that she has carefully read this Agreement and either consulted with legal counsel of Executive’s choosing regarding its contents or knowingly and voluntarily waived the opportunity to do so, has given careful
consideration to the restraints imposed upon Executive by this Agreement and is in full accord as to their necessity for the reasonable and proper protection of confidential and proprietary information of Acadia and the Subsidiaries now existing or
to be developed in the future. Executive expressly acknowledges and agrees that each and every restraint imposed by this Agreement is reasonable with respect to subject matter, duration and geographical area. 

(f)     Specific Performance. In the event of the breach or a threatened breach by Executive of any of the
provisions of Section 5 or 6 or this Section 7, Acadia and the Subsidiaries would suffer irreparable harm and that money damages would not be a sufficient remedy and, in addition and
supplementary to other rights and remedies existing in its favor whether under this Agreement or under any other agreement, the Company shall be entitled to specific performance and/or injunctive or other equitable relief from a court of competent
jurisdiction in order to enforce or prevent any violations of the provisions hereof (without posting a bond or other security). In addition, in the event of an alleged breach or violation by Executive of this Section 7, the
Noncompete Period or the Nonsolicit Period, as applicable, shall be tolled until such breach or violation has been duly cured. 

  
 13 

 8.     Executive’s Representations. Executive hereby
represents and warrants to the Company that (a) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order,
judgment or decree to which Executive is a party or by which she is bound, (b) except as previously disclosed to the Company in writing (a copy of each such agreement having been provided to the Company prior to the date hereof or being
publicly available on EDGAR as of the date hereof), Executive is not a party to or bound by any employment agreement, noncompete agreement or confidentiality agreement with any other person or entity, (c) except as previously disclosed to the
Company in writing, Executive took nothing with her which belonged to any former employer when Executive left her prior position and Executive has nothing that contains any information which belongs to any former employer, in either case which would
reasonably be likely to result in any liability to Acadia or any Subsidiary, and (d) upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in
accordance with its terms. Executive hereby acknowledges and represents that she has either consulted with independent legal counsel regarding her rights and obligations under this Agreement or knowingly and voluntarily waived the opportunity to do
so and that she fully understands the terms and conditions contained herein. 
 9.    Definitions. For purposes
of this Agreement, the following terms shall have the meanings set forth below: 
 “Cause” shall mean with respect to
Executive one or more of the following: (i) the conviction of or plea of nolo contendere to a felony or the conviction of any crime involving misappropriation, embezzlement or fraud with respect to Acadia or any of the Subsidiaries or any of
their customers, suppliers or other business relations, (ii) willful conduct outside the scope of Executive’s duties and responsibilities under this Agreement that causes Acadia or any of the Subsidiaries substantial public disgrace or
disrepute or demonstrable economic harm, (iii) repeated failure to perform duties consistent with this Agreement as reasonably directed by the Board, (iv) any willful act or knowing omission of aiding or abetting a competitor of Acadia or
any of the Subsidiaries to the disadvantage or detriment of Acadia and the Subsidiaries, (v) material breach of fiduciary duty, gross negligence or willful misconduct with respect to Acadia or any of the Subsidiaries, (vi) an
administrative or other proceeding arising as a result of Executive’s action that results in the suspension or debarment of Executive from participation in any contracts with, or programs of, the United States or any of the fifty states or any
agency or department thereof, or any finding of a governmental agency that Executive personally has engaged in misconduct in connection with her employment by the Company or any predecessor employer, or (vii) any other material breach by
Executive of this Agreement (including, but not limited to, breach of the Relocation Requirement) or any other agreement between Executive and Acadia or any of the Subsidiaries, provided that no determination of “Cause” may be made
until Executive has been given written notice detailing the specific Cause event and a period of fifteen (15) business days following receipt of such notice to cure such event. 

  
 14 

 “Disabled” means any physical or mental disability or infirmity that has
prevented the performance of Executive’s duties for a period of (i) one hundred twenty (120) consecutive days or (ii) one hundred eighty (180) non-consecutive days during any twelve (12) month period. Any question as to
the existence, extent or potentiality of Executive’s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company    and
reasonably    approved by Executive (or her representative). 
 “Good Reason” shall mean if Executive
resigns her employment with the Company as a result of one or more of the following actions (in each case taken without Executive’s written consent): (i) a reduction in Executive’s Base Salary, (ii) a material diminution of
Executive’s job duties or responsibilities inconsistent with Executive’s position, which shall include, without limitation, Executive’s removal from the position specified in Section 1(a) or the
Company’s hiring an individual at an equivalent or senior level to Executive to perform substantially the same duties and responsibilities set forth in Section 1(a)); (iii) any other material breach by the Company or
Acadia (or their successors) of this Agreement; or (iv) a relocation of the Company’s and Acadia’s principal executive offices and corporate headquarters outside of a thirty (30) mile radius of Nashville, Tennessee; provided
that, none of the events described in clauses (i) through (iv) above shall constitute Good Reason unless Executive shall have notified the Company and/or Acadia in writing describing the event which constitutes Good Reason within ninety
(90) days after the occurrence of such event and then only if the Company and/or Acadia and the Subsidiaries shall have failed to cure such event within thirty (30) days after the Company’s and/or Acadia’s receipt of such written
notice and Executive elects to terminate her employment as a result at the end of such thirty (30) day period. 

“Person” shall mean an individual, a partnership, a corporation (whether or not for profit), a limited liability company, an
association, a joint stock company, a trust, a joint venture, or other business entity, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof. 

“Subsidiary” shall mean any corporation or other entity of which the securities or other ownership interests having the
voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by Acadia or of which Acadia serves as the managing member or in a similar capacity or of which Acadia holds a majority of
the partnership or limited liability company or similar interests or is otherwise entitled to receive a majority of distributions made by it, in each case directly or through one or more Subsidiaries. 

10.    Survival. Except as otherwise provided in Section 3(g),
Section 4(e), Sections 4 through 28 (other than Section 23) shall survive and continue in full force in accordance with their terms notwithstanding the expiration or termination of
the Employment Period. 

  
 15 

 11.    Notices. Any notice provided for in this Agreement shall
be in writing and shall be personally delivered, sent by facsimile (with hard copy to follow), sent by reputable overnight courier service, or mailed by first class mail, return receipt requested, to the recipient at the address below indicated:

 Notices to Executive: [Executive] 

[REDACTED] with copies (which shall not constitute notice) to: 

Acadia Healthcare Company, Inc. 

6100 Tower Circle, Suite 1000 

Franklin, TN 37067 
 Attention:
General Counsel 
 Facsimile: (615) 261-9685 

Notices to the Company: 
 Acadia
Healthcare Company, Inc. 
 6100 Tower Circle, Suite 1000 

Franklin, TN 37067 
 Attention:
Board of Directors 
 Facsimile: (615) 261-9685 

with copies (which shall not constitute notice) to: 

Acadia Healthcare Company, Inc. 

6100 Tower Circle, Suite 1000 

Franklin, TN 37067 
 Attention:
General Counsel 
 Facsimile: (615) 261-9685 

or such other address or to the attention of such other Person as the recipient party shall have specified by prior written notice to the sending party. Any
notice under this Agreement shall be deemed to have been given when so delivered or sent by facsimile (subject to automatic proof of transmission), one day after being sent by overnight courier or three days after being mailed by first class mail,
return receipt requested, as applicable. 
 12.     Severability. Whenever possible, each provision of this
Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any
jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement or any action in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if
such invalid, illegal or unenforceable provision had never been contained herein. 
 13.    Complete
Agreement. This Agreement and those documents expressly referred to herein embody the complete agreement and understanding among the parties with respect to, and supersede and preempt any prior understandings, agreements or
representations by or among the parties, written or oral, which may have related to, the subject matter hereof in any way. 

14.    No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the
parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any party. 

  
 16 

 15.    Counterparts. This Agreement may be executed in separate
counterparts (including by means of facsimile or by electronic transmission in portable document format (pdf) or comparable electronic transmission), each of which is deemed to be an original and all of which taken together constitute one and the
same agreement. 
 16.    Successors and Assigns. This Agreement is personal in nature and neither of the parties
hereto shall, without the consent of the other, assign, transfer or delegate this Agreement or any rights or obligations hereunder; provided that (i) this Agreement will inure to the benefit of and be enforceable by Executive’s personal or
legal representatives, executors, administrators, successors, heirs, distributees and legatees (but otherwise will not otherwise be assignable, transferable or delegable by Executive), and (ii) this Agreement will be assignable, transferable or
delegable by the Company, without the consent of Executive, to Acadia or any of the Subsidiaries or to any successor (whether direct or indirect, in whatever form of transaction) to all or substantially all of the business or assets of the Company
or Acadia or the Subsidiaries (none of which shall constitute a termination of Executive’s employment hereunder). 

17.    Choice of Law and Forum. All issues and questions concerning the construction, validity, enforcement and
interpretation of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions
(whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. The parties agree that any dispute arising out of or relating to this Agreement,
exclusively shall be brought in the state courts located in Williamson County, Tennessee or the United States District Court for the Middle District of Tennessee. Each party hereby waives any objection to the personal or subject matter jurisdiction
and venue of such courts. 
 18.    Amendment and Waiver. The provisions of this Agreement may be amended or
waived only with the prior written consent of the Company (as approved by the Board) and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the provisions of this
Agreement (including, without limitation, the Company’s right to terminate the Employment Period for Cause) shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of
this Agreement. 
 19.    Insurance. The Company may, at its discretion, apply for and procure in its own name
and for its own benefit life and/or disability insurance on Executive in any amount or amounts considered advisable. Executive agrees to cooperate in any medical or other examination, supply any information and execute and deliver any applications
or other instruments in writing as may be reasonably necessary to obtain and constitute such insurance. 

20.    Indemnification and Reimbursement of Payments on Behalf of Executive. Acadia and the Subsidiaries shall be
entitled to deduct or withhold from any amounts owing from Acadia or any of the Subsidiaries to Executive any federal, state, local or foreign withholding taxes, excise tax, or employment taxes (“Taxes”) imposed with respect to
Executive’s compensation or other payments from Acadia or any of the Subsidiaries or Executive’s ownership interest in Acadia or any of the Subsidiaries (including, without limitation, wages, bonuses, dividends, the receipt or exercise of
equity options and/or the receipt or vesting of restricted equity), as may be required to be deducted or withheld by any applicable law or regulation. 

  
 17 

 21.    Executive Representation. Executive has provided the
Company with copies of all agreements with Executive’s former employer (the “Former Employer”) that contains post- termination restrictive covenants (the “Former Employer Covenants”). Executive agrees to comply
with the Former Employer Covenants and the parties agree to communicate among themselves in order to determine how best to so comply. To that end, Executive shall not perform any services for, or continue or assume any position with, the Company or
its Affiliates to the extent it is determined by the parties that such services or actions would violate the Former Employer Covenants, it being understood and agreed that this shall not constitute Good Reason hereunder. The Company hereby agrees to
indemnify, defend and hold harmless Executive from and against any and all Covered Costs (defined below) related to or arising out of any Covered Claim (and/or any claim, action, suit or proceeding brought by or on behalf of Executive to enforce any
of the provisions of this paragraph of this Agreement). Without limitation of the foregoing, the Company will advance all expenses incurred by Executive in connection with the investigation, defense, settlement or appeal of any proceeding to which
Executive is a party or is threatened to be made a party by reason of any action by any Former Employer and/or any Claim by a Former Employer with respect to Executive’s employment with the Company or Acadia or their Subsidiaries. Executive
hereby agrees to resolve any such investigation, defense, settlement or appeal, as reasonably directed by the Company and/or Acadia. In the event Executive does not comply with the immediately preceding sentence, Executive shall not be entitled to
any further indemnification or reimbursements provided for in this Section 21. “Covered Costs” means all reasonable fees and expenses of counsel, experts and other advisors, including, without limitation,
reasonable attorneys’ fees, retainers, court costs, witness fees, travel expenses, and all other reasonable disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend,
investigating, being or preparing to be a witness in, or otherwise participating in, any threatened, pending or completed action, suit or proceeding, including, without limitation, any appeals, whether administrative or arbitrative and whether
formal or informal, together with any and all damages, judgments, settlements, penalties, fines or other amounts assessed against Executive or for which Executive may be held liable. “Covered Claim” means any and all claims,
actions, suits or proceedings, whether actual, threatened, pending or completed arising from or relating to any alleged breach of any agreement between Executive and the Former Employer and/or any of its parents, subsidiaries, divisions, or
affiliates as a result of Executive’s employment by, and/or contracting with, the Company, Acadia or their Affiliates, including, but not limited to, the Former Employer Covenants, provided that a Covered Claim shall not apply to any willful or
grossly negligent breach of the Former Employer Covenants by Executive. 
 22.     Waiver of Jury Trial. AS A
SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT (AFTER HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL), EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR PROCEEDING
RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY. 

  
 18 

 23.    Opportunity. During the Employment Period, Executive shall
submit to the Board all material investment or business opportunities of which she becomes aware that would customarily be brought to the attention of a board of directors and which are within the scope and investment objectives of Acadia or any of
the Subsidiaries. 
 24.    Executive’s Cooperation. During the Employment Period and for a period of six
(6) months thereafter, Executive shall cooperate with Acadia and the Subsidiaries in any internal investigation or administrative, regulatory or judicial investigation or proceeding or any dispute with any third party as reasonably requested by
Acadia or the Subsidiaries (including, without limitation, Executive being available to Acadia and the Subsidiaries upon reasonable notice for interviews and factual investigations, appearing at Acadia’s or any of the Subsidiaries’ request
to give testimony without requiring service of a subpoena or other legal process, volunteering Acadia and the Subsidiaries all pertinent information and turning over to Acadia and the Subsidiaries all relevant documents which are or may come into
Executive’s possession, all at times and on schedules that are reasonably consistent with Executive’s other permitted activities and commitments), all at Acadia’s or the Subsidiaries’ sole cost and expense. After such six
(6) month period, if Executive is requested to engage or participate in any of the foregoing, then Executive will do so and Acadia or the Subsidiaries shall compensate Executive for her time at an hourly rate of $250/hour. Any services
requested by the Company under this Section 24 shall be scheduled to not unreasonably interfere with Executive’s employment or personal obligations at the time. It is expressly agreed that the Company’s rights to avail itself of the
advice and consultation services of Executive shall at all times be exercised in a reasonable manner, that adequate notice shall be given to Executive in such events, and that non-compliance with any such request by Executive for good reason,
including, but not limited to, ill health or prior commitments, shall not constitute a breach or violation of this Agreement. 

25.    Delivery by Facsimile or PDF. This Agreement, the agreements referred to herein, and each other agreement or
instrument entered into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or electronic transmission in pdf, shall be
treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto or to
any such agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties. No party hereto or to any such agreement or instrument shall raise the use of a facsimile machine or
electronic transmission in pdf to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or electronic transmission in pdf as a defense to the formation or
enforceability of a contract and each such party forever waives any such defense. 
 26.    Indemnification and
Directors and Officers Insurance. 
 (a) During the Employment Period and for a period of six (6) years thereafter, the Company
shall, to the fullest extent permitted under applicable law, indemnify and hold harmless Executive on a basis no less favorable than members of the Board and in accordance with the bylaws of the Company and Acadia. 

  
 19 

 (b)     During the Employment Period and for a period of six
(6) years thereafter, the Company, or any successor to the Company, shall purchase and maintain, at its own expense, directors and officers liability insurance providing coverage for Executive in the same or greater amount as for members of the
Board. 
 27.    Legal Fees and Expenses. In the event any litigation or other court action, arbitration or
similar adjudicatory proceeding (a “Proceeding”) is commenced or threatened by any party hereto (the “Claiming Party”) to enforce its rights under this Agreement against any other party hereto (the
“Defending Party”), if the Defending Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation, reasonable attorneys fees and court costs, incurred by the Defending Party in such
Proceeding, will be reimbursed by the Claiming Party, and, if the Claiming Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation, reasonable attorneys fees and court costs, incurred by the
Claiming Party in such Proceeding, will be reimbursed by the Defending Party; provided that if the Defending Party prevails in part, and loses in part, in such Proceeding, the court, arbitrator or other adjudicator presiding over such Proceeding
shall award a reimbursement of the fees, costs and expenses incurred by the Claiming Party and the Defending Party on an equitable basis. For purposes of this Section 27, and without limiting the generality of the
foregoing, the Defending Party will be deemed to have prevailed in any Proceeding if the Claiming Party commences or threatens such Proceeding and (i) the underlying claim(s) in such Proceeding are subsequently dropped or dismissed, or
(ii) the Defending Party defeats any such claim(s). 
 28.     Acadia Guarantee. Acadia unconditionally
guarantees and promises to pay and perform, upon Executive’s demand following a default by the Company, any and all obligations of the Company from time to time owed to Executive under this Agreement, subject to any applicable cure period.
Acadia further agrees that if the Company shall fail to fulfill any of its obligations under this Agreement, Acadia will perform the same on demand as a principal obligor, and not as a surety. This is a continuing guarantee of the obligations and
may not be revoked and shall not otherwise terminate unless and until the obligations of the Company have been paid and performed in full. Acadia represents and warrants that it will receive a substantial benefit from Company’s employment of
Executive, which employment gives rise to the obligations of the Company under this Agreement. Acadia acknowledges that Executive would not execute this Agreement if it did not receive this guarantee. 

*            *           
 *            *            * 

  
 20 

 IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the
date first written above. 
  

			
	COMPANY:
	
	ACADIA MANAGEMENT COMPANY, INC.
		
	By:	 	 /s/ Reeve B. Waud

	Name:	 	Reeve B. Waud
	Its:	 	Director
	
	EXECUTIVE:
	
	 /s/ Debra K. Osteen

	Name:	 	Debra K. Osteen
	
	ACKNOWLEDGED AND AGREED:
	
	ACADIA HEALTHCARE COMPANY, INC., solely with respect to Sections 7 and 28, as of this    day of December, 2018
		
	By:	 	 /s/ Reeve B. Waud

	Name:	 	Reeve B. Waud
	Its:	 	Director

 Schedule 1 

1.    The Company will pay Executive a cash lump sum of $350,000 promptly after the Effective Date. 

2.    The Company will pay Executive a cash lump sum of $2.5 million on the first anniversary of the Effective Date
if the Executive is then employed by the Company. 
 3.    Promptly after the Effective Date, in addition to the awards
set forth in Section 3(d) of the Agreement, the Company will issue the Executive restricted stock units having a grant date fair value on the Effective Date (the “Grant Value”) of $6.65 million (the
“RSUs”). The RSUs will vest and be settled as follows: 50% of the RSUs will vest and be settled on each of the first two anniversaries of the Effective Date, respectively, subject to Executive’s continued employment through
each applicable vesting date. 
 4.    The Grant Value with respect to any unvested RSUs will be reduced on a dollar-
for-dollar basis by any unrestricted amounts received by Executive in respect of stock options issued by her former employer and held by Executive on December 12, 2018. If directed by the Company, Executive will institute legal proceedings against
her former employer to receive some or all of such amounts, with the cost of such proceedings advanced and paid on a net after- tax basis by the Company (this obligation shall survive the expiration of the Agreement and Executive’s termination
of employment with the Company). 
 5.    Notwithstanding the foregoing, any unvested amounts described in paragraphs 2
or 3 of this Schedule 1 will accelerate and fully vest if Executive’s employment with the Company is terminated (i) due to death or Disability, (ii) by the Company for a reason other than Cause, or (iii) by Executive for Good
Reason. Such acceleration shall be subject to Executive’s timely execution and non-revocation of a general release of claims in favor of the Company in substantially the form attached on Exhibit B hereto with such release to be executed
(and no longer subject to revocation, if applicable) within sixty (60) days following Executive’s termination. 

  
 22 

 Exhibit A 

Other Activities 
  

	 	•	 	 National Alliance of Suicide Prevention 

 

	 	•	 	 National Association of Behavioral Health 

 Exhibit B1 

GENERAL RELEASE 

I,             , in consideration of and subject to the performance by Acadia
Management Company, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), of its obligations under the Employment Agreement dated as of December 16, 2018 (the “Agreement”), do hereby release
and forever discharge as of the date hereof the Company and its respective affiliates and all present, former and future managers, directors, officers, employees, successors and assigns of the Company and its affiliates and direct or indirect owners
(collectively, the “Released Parties”) to the extent provided below (this “General Release”). The Released Parties are intended to be third-party beneficiaries of this General Release, and this General
Release may be enforced by each of them in accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement. 

1.    I understand that any payments or benefits paid or granted to me under Section 4 of the Agreement represent, in
part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain of the payments and benefits specified in Section 4, unless I
execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any employee benefit plan, program, policy or arrangement
maintained or hereafter established by the Company or its affiliates. 
 2.    Except as provided in paragraphs 5 and 6
below and except for the provisions of the Agreement which expressly survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge
the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages,
punitive or exemplary damages, other damages, claims for costs and attorneys’ fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date that this General Release becomes effective and
enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, including those that arise out of or are
connected with my employment with, or my separation or termination from, the Company (including, but not limited to, any allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of
1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993;
the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal,
state or local civil or human rights law, or 
  

	1 	 Note to Draft: Subject to updates to the extent necessary for applicable governing law.

  
 24 

 
under any other local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices or procedures of
the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including attorneys’ fees incurred in these matters) (all of the foregoing
collectively referred to herein as the “Claims”). 
 3.    The released claims described in paragraph 2
hereof include all such claims, whether known or unknown by me. 
 4.    I represent that I have made no assignment or
transfer of any right, claim, demand, cause of action, or other matter covered by paragraph 2 above. 
 5.    I agree
that this General Release does not waive or release any rights or claims that I may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation
from employment with the Company in compliance with the terms of the Agreement shall not serve as the basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). 

6.    I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all
Released Parties of any kind whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not
being required to waive any right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim and waive any
right to share or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding. Additionally, I am not waiving (and nothing set forth herein shall be deemed a release of) (i) any right to any
earned and accrued salary, vacation, benefits, expense reimbursements, or any severance benefits to which I am entitled under the Agreement, or any rights under Sections 3(f) or 3(g) of the Agreement, (ii) any claim relating to directors’
and officers’ liability insurance coverage or any right of indemnification under the Company’s organizational documents, applicable law or otherwise, including, without limitation, Sections 21, 26, and 27 of the Agreement and/or
(iii) my rights as an equity or security holder in the Company, Acadia or their affiliates. 
 7.    In signing
this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to
each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims (notwithstanding any state or local statute that expressly limits the effectiveness of a general release of unknown, unsuspected and
unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the
Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a
governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent permitted by law. I further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of
the execution of this General Release. 

  
 25 

 8.    I agree that neither this General Release, nor the furnishing of
the consideration for this General Release, shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. 

9.    I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all
costs and expenses of defending against the suit incurred by the Released Parties, including reasonable attorneys’ fees. 

10.    Any non-disclosure provision in this General Release does not prohibit or restrict me (or my attorney) from
responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization or any
governmental entity. 
 11.    I hereby acknowledge that Sections 4 through 28 (other than Section 23) of the
Agreement shall survive my execution of this General Release. 
 12.    I represent that I am not aware of any claim by
me other than the claims that are released by this General Release. I acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the
release set forth in paragraph 2 above and which, if known or suspected at the time of entering into this General Release, may have materially affected this General Release and my decision to enter into it. 

13.     Notwithstanding anything in this General Release to the contrary, this General Release shall not relinquish,
diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof. 

14.    Whenever possible, each provision of this General Release shall be interpreted in, such manner as to be effective
and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall
not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. 

BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: 
  

	 	(a)	 I HAVE READ IT CAREFULLY; 

 

	 	(b)	 I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO,
RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED; TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963; THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT
OF 1974, AS AMENDED; 

  
 26 

	 	(c)	 I VOLUNTARILY CONSENT TO EVERYTHING IN IT; 

 

	 	(d)	 I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL
READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION; 

  

	 	(e)	 I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE
CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD; 

  

	 	(f)	 I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; 

  

	 	(g)	 I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO
ADVISE ME WITH RESPECT TO IT; AND 

  

	 	(h)	 I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY
AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. 

  

							
	SIGNED:	  	  
	  	DATED:	  	  

  
 27

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]